Table of Content

Open Access iconOpen Access

REVIEW

Information that affects patients’ treatment choices for early stage prostate cancer: a review

Deb Feldman-Stewart1,2, Michael D. Brundage1,2,3, Christine Tong1

1 Division of Cancer Care and Epidemiology, Queen’s University, Kingston, Ontario, Canada
2 Department of Oncology, Queen’s University, Kingston, Ontario, Canada
3 Department of Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada
Address correspondence to Dr. D. Feldman-Stewart, Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute, Level 2, 10 Stuart Street, Kingston, Ontario K7L 3N6 Canada

Canadian Journal of Urology 2011, 18(6), 5998-6006.

Abstract

Introduction: We conducted a systematic review of primary evidence to clarify what information influences treatment selection by patients with early stage prostate cancer.
Materials and methods: We conducted a systematic review of the Web of Knowledge, using the ALL DATABASES option. Papers were then triaged out on the basis of the title and/or abstract, leaving 120 papers. Reviewing the full papers resulted in a final corpus of 21 papers.
Results: The data suggest that patients typically balance potential benefits against potential side effects but in a complex way with large variation across patients. For some patients, potential benefits relate to chances of survival but, for others, relate to control over cancer spread. The most common potential harm is effect on bladder functioning but even that is not a concern of all patients. Similarly, potential impact on bowel and on sexual functioning affects some patients' decisions but not others. Patient decisions are also affected by information not typically identified as affecting this decision. These include aspects of treatment and decision processes, competencies, and others' opinions, again, with wide variation across patients. The patient's view of which information items affect his decision may also change over time, consistent with a dynamic decision-making process.
Conclusions: Decision support interventions are needed to optimally tailor information for decision-making to the individual patient, and should be designed to accommodate the illustrated variation in patients' needs.

Keywords

prostate cancer, treatment decision making, patient preferences, patient education

Cite This Article

APA Style
Feldman-Stewart, D., Brundage, M.D., Tong, C. (2011). Information that affects patients’ treatment choices for early stage prostate cancer: a review. Canadian Journal of Urology, 18(6), 5998–6006.
Vancouver Style
Feldman-Stewart D, Brundage MD, Tong C. Information that affects patients’ treatment choices for early stage prostate cancer: a review. Can J Urology. 2011;18(6):5998–6006.
IEEE Style
D. Feldman-Stewart, M.D. Brundage, and C. Tong, “Information that affects patients’ treatment choices for early stage prostate cancer: a review,” Can. J. Urology, vol. 18, no. 6, pp. 5998–6006, 2011.



cc Copyright © 2011 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 137

    View

  • 103

    Download

  • 0

    Like

Share Link